22.04.2014 Views

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SRA 2013 Annual Meeting <strong>Abstracts</strong><br />

M2-C.4 Hoss, F*; Vaishnav, P; Carnegie Mellon University;<br />

fhoss@andrew.cmu.edu<br />

What guides spending on risk mitigation: Perceptions or<br />

statistics?<br />

People perceive risks on numerous dimensions. They care about<br />

different risks more or less than the expected losses from those<br />

risks would justify. This puts policymakers in a quandary.<br />

Should they prioritize their risk mitigation ef<strong>for</strong>ts and resources<br />

based on people’s perceptions, or based on some ‘objective’<br />

assessment? Policymakers do not spend equally on mitigating<br />

different risks. For example, a wide range of values of<br />

statistical life that can be inferred from a range of proposed<br />

and actual policy interventions that would reduce the risk of<br />

premature mortality. Our research will compare what different<br />

countries – in the first instance, the US and the countries of the<br />

EU – spend on mitigating different risks. Based on published<br />

data, we will work out what the expected value of losses<br />

associated with these risks are in each of the countries. Based<br />

on survey data, we will find out how residents of these<br />

countries perceive each of these risks: <strong>for</strong> example, to what<br />

extent do they think the risk is voluntary. We will then work out<br />

whether spending priorities are more closely correlated with<br />

expected value of losses or perceived risks in one country or<br />

another, and try to explain why these correlations are different.<br />

For example, the US and Europe have different approaches to<br />

risk mitigation is in the detection and treatment of cancer.<br />

Europeans are more likely to die of certain cancers than<br />

Americans. A possible explanation is that there is a greater<br />

emphasis on regular scans in the US. Surveys suggest that<br />

Europeans dread cancer, and place a greater value on<br />

preventing the loss of life due to cancer than due to other<br />

causes. Why, then, do Europeans place less emphasis on<br />

scanning <strong>for</strong> cancer? Is this a historical artefact? Is this a<br />

choice policymakers have made despite public opinion? Do<br />

Europeans dread cancer less than Americans do? Do<br />

policymakers with different professional backgrounds reach<br />

different decisions? Our research will answer such questions.<br />

T1-C.3 Hoss, F; CARNEGIE MELLON UNIVERSITY,<br />

Pittsburgh; fhoss@andrew.cmu.edu<br />

The clients of the National Weather Service: Does the<br />

current use of river <strong>for</strong>ecasts fully exploit their potential<br />

to decrease flood risk?<br />

For thousands of river gages, the National Weather Service<br />

daily publishes the expected river-stage <strong>for</strong> the next few days.<br />

Good river <strong>for</strong>ecasts have skill <strong>for</strong> up to two days ahead,<br />

meaning that they per<strong>for</strong>m better than assuming that water<br />

level will not change. For more lead time, especially when<br />

extreme events are concerned, the <strong>for</strong>ecast error grows rapidly.<br />

It is not uncommon that <strong>for</strong>ecasts <strong>for</strong> river-stages in the 90th<br />

percentile of observed river-stages have average errors of<br />

several feet. The river <strong>for</strong>ecast centers of the National Weather<br />

Service do not yet publish the uncertainty or expected error<br />

associated with these short-term <strong>for</strong>ecasts. It follows that<br />

successful use of river <strong>for</strong>ecasts is heavily dependent on the<br />

understanding of the uncertainty of <strong>for</strong>ecasts. For example,<br />

ignorance of the average errors of <strong>for</strong>ecasts <strong>for</strong> the Red River<br />

led to insufficient preparation of Grand Forks, ND and its<br />

subsequent flooding in 1997. This research focuses on the users<br />

of river <strong>for</strong>ecasts in emergency management. Central questions<br />

are if the emergency managers have the knowledge to correctly<br />

use the <strong>for</strong>ecasts and what the benefits of river <strong>for</strong>ecasts as<br />

they are used today are. Do river <strong>for</strong>ecasts as they are<br />

published today reduce the flood risk, e.g. the likelihood to<br />

suffer damage from flooding? To investigate these questions, 17<br />

emergency managers of mostly small and medium-sized<br />

communities along rivers in Pennsylvania and Oklahoma have<br />

been interviewed. The analysis is structured as follows. First,<br />

the emergency <strong>for</strong>ecasters themselves are described. Which<br />

education and experience do they have? How much do they<br />

know about the <strong>for</strong>ecasting process and the resulting<br />

uncertainty? Second, the process of preparing <strong>for</strong> an<br />

approaching flood and the role of river <strong>for</strong>ecasts therein is<br />

analyzed. Third, the research zooms in on the use of the<br />

<strong>for</strong>ecast. Which <strong>for</strong>ecasts are being used and through what<br />

channels are they accessed? The research is rounded off with a<br />

discussion on how river <strong>for</strong>ecast could reduce flood risk if they<br />

were used more effectively.<br />

T4-D.5 Hristozov, DH*; Wohlleben, W; Steinfeldt, M; Nowack,<br />

B; Scott-Fordsmand, J; Jensen, KA; Stone, V; Costa, A; Linkov, I;<br />

Marcomini, A; University Ca' Foscari Venice;<br />

danail.hristozov@unive.it<br />

Sustainable nanotechnologies (SUN)<br />

Our understanding of the environmental and health risks<br />

associated with nanotechnology is still limited and may result in<br />

stagnation of growth and innovation. There have been other<br />

technologies that revealed unexpected ecological and health<br />

effects only several years after their broader market<br />

introduction. In the worst cases this caused tremendous costs<br />

<strong>for</strong> society and the enterprises in the <strong>for</strong>m of lock-in effects,<br />

over-balancing regulations and demolished consumer<br />

confidence. The new European Seventh Framework Programme<br />

SUN (Sustainable Nanotechnologies) project, worth 14 million<br />

euro, is based on the hypothesis that the current knowledge on<br />

environmental and health risks of nanomaterials, whilst limited,<br />

can nevertheless guide nanomanufacturing to avoid future<br />

liabilities. SUN goal is to develop and apply an integrated<br />

approach that addresses the complete lifecycle of production,<br />

use and disposal of nanomaterials to ensure holistic safety<br />

evaluation. The project will incorporate scientific findings from<br />

over 30 European projects, national and international research<br />

programmes and transatlantic co-operation to develop methods<br />

and tools to predict nanomaterials exposure and effects on<br />

humans and ecosystems, implementable processes and<br />

innovative technological solutions to reduce their risks, and<br />

guidance on best practices <strong>for</strong> securing both<br />

nano-manufacturing processes and nanomaterials ultimate fate,<br />

including development of approaches <strong>for</strong> safe disposal and<br />

recycling. The results will be integrated into tools and<br />

guidelines <strong>for</strong> sustainable manufacturing, easily accessible by<br />

industries, regulators and other stakeholders.The industrial<br />

partners in the SUN consortium will evaluate and<br />

“reality-check” these tools in case studies in terms of<br />

cost/benefit and insurance risk. The project involves major<br />

stakeholders such as OECD, ECHA, US EPA in implementing<br />

the SUN results into practice and regulation.<br />

P.62 Huang, Y*; Anderson, S; Yang, H; The US Food and Drug<br />

Administration; Yin.Huang@fda.hhs.gov<br />

Modeling the relationship between post-vaccination<br />

hemagglutination inhibition (HI) titer and protection<br />

against influenza<br />

The objective of this research is to evaluate the relationship<br />

between post-vaccination HI titer in the host and the protection<br />

against influenza using modeling approaches. The HI titer is<br />

currently used as a surrogate endpoint <strong>for</strong> protection against<br />

diseases in FDA’s regulatory review of influenza vaccine<br />

products. We expect that the results of this research will<br />

provide us an insight on whether HI titer is a good predictor of<br />

protection against influenza; and if it is, what the level of HI<br />

titer needed <strong>for</strong> a sufficient protection is. We first searched<br />

available data from human challenge studies that reported<br />

post-vaccination HI titer, challenge dose, and post-challenge<br />

influenza infection. Five large-scale studies were identified.<br />

Among them, four studies used single doses <strong>for</strong> challenge while<br />

one reported multiple-dose challenge. We grouped the<br />

volunteers based on their HI titer levels. We assumed the<br />

relationship between challenge dose and infection rate<br />

(response) could be described by exponential or beta-Poisson<br />

dose-response models that have been widely used <strong>for</strong> a number<br />

of infectious disease agents. We estimated the model<br />

parameters <strong>for</strong> each HI titer group, and examined the<br />

dependency between host susceptibility represented by model<br />

parameters and post-vaccination HI titer. The dose-response<br />

models were further modified by incorporating such<br />

dependency and fit to the data set with graded challenge doses<br />

using maximum likelihood estimation. An exponential<br />

dependency between the model parameters and HI titer was<br />

identified and the dose-response models incorporating this<br />

dependency provided statistically acceptable fit to the data<br />

while the original models failed to do so. The modified models<br />

can be potentially used to identify the critical level of<br />

post-vaccination HI titer required <strong>for</strong> sufficient protection<br />

against influenza; and there<strong>for</strong>e, enhance our ability to evaluate<br />

the efficacy and protection offered by future candidate<br />

influenza vaccines.<br />

December 8-11, 2013 - Baltimore, MD

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!